Showing    of 136 results

Helix spiral

New Platform Analyzes Patients Genomic Biomarkers to Match with Available Clinical Trials Nationwide

March 2021

Team at UH Seidman Cancer Center Identifies Robust Immune Biomarker Predicting Survival in HPV-positive Head and Neck Squamous Cell Carcinoma

Findings can guide which patients are best candidates for de-escalation strategies - Innovations in Cancer | March 2021

Image of herbs and medicine

Chemotherapy Patients Who Take Herbs and Supplements at Risk of Serious Medication Interactions, Study Shows

Patients in study are largely unaware of the risk - Innovations in Cancer | February 2021

Abbreviated breast MRI scan

An Early Adopter of Abbreviated Breast MRI, UH Posts Noteworthy Early Results

Program has identified 19.9 breast cancers per 1,000 studies - Innovations in Cancer | Winter 2021

Helix spiral

Novel Gene Therapy Treatment for Glioblastoma Moves Forward at UH Seidman Cancer Center

Phase II clinical trial of promising approach soon to begin at UH Seidman and second site at the NIH Clinical Center - Innovations in Cancer | Winter 2021

Mesothelin - positive

New Immunotherapy Center at UH Seidman Cancer Center Sets the Stage for Solutions

Center offers dozens of clinical trials, including soon a rare all-human protein CAR T trial for patients with certain hematologic malignancies - Innovations in Cancer | Winter 2021

AI Tumor response image

UH Seidman Cancer Center and Case Western Reserve University Collaborate on AI Tool to Predict Treatment Response

Tool uses outcomes data from more than 700 UH Seidman oropharyngeal cancer patients - Innovations in Cancer | Winter 2021

Medtronic Stealth Autoglide platform

UH Introduces Stealth Autoguide™ for Precision Neurosurgery

New robotic guidance platform reduces risk for patients undergoing complex brain surgery - Innovations in Neurology & Neurosurgery | Winter 2021

Results are loading...